Loading...
The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity
Due to the increase in the number of infliximab products, the need for global harmonization of the bioactivity of this monoclonal antibody was recognized by the World Health Organization (WHO). In response, the National Institute for Biological Standards and Control (NIBSC) developed the first inter...
Na minha lista:
| Udgivet i: | MAbs |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343779/ https://ncbi.nlm.nih.gov/pubmed/30395763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1532766 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|